Pten knockout affects drug resistance differently in melanoma and kidney cancer

CONCLUSIONS: The results confirmed heterogenous cell responses to PTEN loss, which may lead to a better understanding of the role of PTEN in particular types of tumors and points to PTEN as a therapeutic target for personalized medicine.PMID:37673853 | DOI:10.1007/s43440-023-00523-y

Source: Pharmacological Reports - September 6, 2023 Category: Drugs & Pharmacology Authors: Klaudia Brodaczewska Aleksandra Majewska Aleksandra Filipiak-Duliban Claudine Kieda Source Type: research